NCT00561886View on ClinicalTrials.gov

Change of Inspiratory Peak Flow in COPD

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

April 30, 2007

Study Completion Date

October 31, 2007

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Formoterol

One inhalation of 24µg Formoterol

Trial Locations (1)

Unknown

Johannes Gutenberg-Univeristy, Mainz

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Johannes Gutenberg University Mainz

OTHER